Cabecera

Tipo Convocatoria: JOB OFFERS

Información de la Convocatoria

23-175_SS_VN Study Coordinator for Early Clinical Trials in Haematology

Presentación de Solicitudes

Desde: 23/06/2023 0:00 (UTC+01:00) Brussels, Copenhagen, Madrid, Paris

Hasta: 17/07/2023 23:59 (UTC+01:00) Brussels, Copenhagen, Madrid, Paris

Información:

Study Coordinator for Early Clinical Trials in Haematology

 

Reference: 23-175_SS_VN

About the research group

Hematopoyetic and lymphoid tumors

ICO-L’Hospitalet is a reference hospital for the clinical research in cancer. Their two units (UIC and UFF1) have been participating in 506 clinical trials with active recruitment or with current activities during 2021 and 747 patients decided to participate in them. Many of these trials are testing the most promising therapies in cancer and investigators involved in them are specialized and up-to-date with the latest advances in new treatments. UIC and UFF1 units have the best professionals who carry out the most demanding clinical trials.

About the role

  • Coordination of Oncology Clinical Trials into Functional Phase I Unit for:
    • Performance and application of coordinated procedures between the different clinical services involved in the inclusion, treatment and follow-up of patient’s participation.
    • Support to Investigators and electronic tools implementation
    • Management of human tissues between different external referring sites
  • Record of transactions in sponsor’s systems (IWR). Record of trial and patient’s information into clinical and research applications
  • Administrative procedures during the study
  • SAE completion
  • Case Report Form training, completion and correction. Queries resolution.
  • Communication with Sponsors and CROs
  • Preparation and attention to monitoring visits, audits and inspections, internal and external information meetings

Job requirements

Professional experience

  • At minimum of 6 months of experience in oncology or hematology cancer clinical trials (as a coordinator or a data entry)
  • Coordination or data entry in phase I, II and III cancer trials

Education and training

  •  Bachelor degree in Life Sciences
  •  Education in clinical trials and clinical research
  •  Education in Good Clinical Practices

Technical & soft skills 

  • MS Office (Outlook, Excel, Word), internet, patient’s files 
  • Internet Browsers (Firefox, Chrome, Edge) and Patient’s Files
  • To organize, order, and perform different activities with knowledge of their influence on the final outcome of a process
  • Understand the points of view of other people, give help. Ability to work under pressure

Languages

  •  Good command of the English language

 

We will value, but not required

  • Experience as Clinical trials Monitor
  • Familiarity with SAP Argos Electronic Medical Record system
  • Previous experience in data management of oncology studies
  • Previous experience in clinical trials (other than cancer)

What do we offer

  • No. of positions:   1

  • Estimated start date:  August 2023

  • Contract duration:  Permanent linked to projects

  • Estimated annual gross salary:  29.900 €

  • You will be part of a multicultural team. We have a fun loving and friendly international work environment.

  • Flexible working schedule - We know you have a life outside of work and we will work with you to make sure it's kept that way.

  • Possibility to work some days in remote -Teleworking

  • 26 working days of holiday per year

  • System of accumulated hours for employees, from 88 to 104 hours depending on the year (11 to 13 working days), to attend to personal matters.

  • Paid leave package

  • Benefits of constant training are offered

  • We offer and promote diverse and inclusive conditions. Applicants are made free from any discrimination. Specifically IDIBELL works to improve gender equality in all areas with the aim of achieving gender balance, but maintaining the most scrupulous respect to any choice at the level of gender identity. Please express yourself freely, safely and non-binarily, if that's the case.

Selection process

  • Pre-selection: The pre-selection process will consist on an eligibility check based on qualifications and expertise reflected on the candidate's CV.
  • Interview: Best positioned, pre-selected candidates may be called to arrange an interviewCandidates will be interviewed by the hiring manager and an ad hoc selection panel.
  • Formal offer letter: Once identified, the Talent Unit will send a job offer to the successful candidate indicating start date, salary, working conditions, and any additional relevant details.

 

Deadline: Please submit your application by 17 July 2023

 

Data protection notice

In compliance with the obligations established in the General Regulation of Data Protection (RGPD), which is the Regulation (EU) 2016/679 of the Parliament and of the Council, of April 27, 2016, and the Organic Law 3/2018, of December 5, Protection of Personal Data and guarantee of digital rights, it is reported that the Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), CIF G58863317, with address Av. Granvia de l'Hospitalet, 199-203, 08908, L'Hospitalet de Llobregat, will process your personal data, as the controller, to apply for the position, maintain communication concerning the status of the candidature, to access the delivered CV; to compare that your data is in accordance with the offers announced by IDIBELL and to verify, where appropriate, that the information provided is accurate. You can find more information in our Privacy Policy at https://idibell.cat/en/privacy-policy-2/, request more information about the data processing carried out and exercise your rights of access, rectification, deletion, opposition, portability, limitation of processing by sending a request at email: dataprotection@idibell.cat. If you consider that you have not obtained satisfaction in exercising your rights, you may submit a claim to Catalan Data Protection Authority.

 

Our institute

IDIBELL is a research center that integrates the biomedical research of the Bellvitge University Hospital (HUB), the Catalan Institute of Oncology (ICO), and the University of Barcelona in the Bellvitge Campus (UB), and the Viladecans Hospital (HV). The research focuses of IDIBELL are cancer, neuroscience, translational medicine and regenerative medicine. Research, innovation and society are the pivots on which researchers work every day in order to improve the quality of life of citizens.

Observations

The 'HR Excellence in Research' award represents IDIBELL’s commitment to the implementation of Human Resources policies, which oversee the attracting and development of talent in an open, transparent, and based on personal merit, in alignment with the principles of the European Charter for Researchers and the Code of Conduct for the Recruitment Researchers (Charter and Code).

IDIBELL is committed to the principles of the Code of Conduct for the Recruitment of Researchers of the European Commission and the implementation of open, transparent and merit-based recruitment (OTMR).

HR_logo.png
Logo_Centres_de_Recerca_de_Catalunya_(CERCA).jpg

Documentación

Bases de la Convocatoria